SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to stocks like SMX. Community members are highlighting key price levels as potential triggers for further upward momentum. Speculation is fueled by social media buzz around a prior AI server deal and the company's structure after a reverse split.

Amplify ETF Trust - Amplify Seymour Cannabis ETF

Amplify Seymour Cannabis ETF

$CNBS is trending due to renewed sector-wide optimism fueled by reports that the Trump administration may reclassify marijuana, potentially leading to significant tax relief and easier access to banking services for cannabis companies. The community is closely watching for details on the executive order, with some expressing skepticism while others highlight Tim Seymour's connection to the ETF. Overall, the ETF's volatility and potential for rapid price swings are key discussion points.

Tennant Co. engages in the design, manufacture, and marketing of cleaning solutions. Its products include equipment for maintaining surfaces in industrial, commercial, and outdoor environments, detergent-free and other sustainable cleaning technologies, cleaning tools and supplies, and coatings for protecting, repairing and upgrading surfaces. It operates through the following geographic segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by George Henry Tennant in 1870 and is headquartered in Eden Prairie, MN.

Tennant Co.

Tennant Co. is trending as investors are evaluating a potential acquisition of Nilfisk amidst a competitive bidding environment, with some believing a merger would create synergies. Community members are also assessing the company's strategic direction, particularly regarding expansion in smaller space cleaning and the potential impact of robotics and AI. Overall sentiment is mixed, with some viewing $TNC as undervalued, while others are wary of insider selling.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint & redeem rTokens.

StaFi

StaFi's FIS token is trending amid discussions around its potential for a major price shift, particularly in relation to a descending wedge pattern and key price levels; however, a recent Binance delisting announcement has introduced concerns about volatility and potential downsides. The community is weighing the delisting news against StaFi's ongoing efforts to expand its multi-chain liquid staking infrastructure and develop AI-powered systems, creating a mixed sentiment.

The Root Network

The Root Network ($ROOT) is trending as the community discusses its potential within the metaverse and its connection to Futureverse. Conversations revolve around recent price movements, accumulation strategies, and speculation about a potential breakout similar to other metaverse projects. Some users are also highlighting partnerships and the project's ecosystem, while others are inquiring about price discrepancies across exchanges.

Berachain

Berachain ($BERA) is trending as traders discuss its Proof-of-Liquidity model and potential for future growth, while others express concerns about its performance since launch. Community members are actively debating entry points and discussing potential price targets. The recent Bectra upgrade and integrations with platforms like PAW Chain are also sparking interest.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around the idea of a decentralized retirement fund, challenging traditional 401(k) plans. Discussions highlight upcoming staking and the project's evolution from a meme to a potential financial movement. Despite some price volatility, the community expresses strong conviction and a belief in the project's long-term vision.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is experiencing increased community chatter driven by its recent listing on Robinhood, with users speculating on increased exposure and easier access for U.S. retail investors. Bullish sentiment is further fueled by upcoming Goliath Mainnet, with some seeing the Robinhood listing as a signal of legitimacy and visibility. Community members are also sharing price predictions and discussing staking percentages.

Marriott International, Inc. engages in the operation and franchise of hotel, residential, and timeshare properties. It operates through the following geography segments: United States and Canada, Europe, Middle East, and Africa, Asia Pacific, and Greater China. Its brands include Marriott Bonvoy, The Ritz-Carlton, Edition, W Hotels Worldwide, The Luxury Collection, and Stregis Hotels and Resorts etc. The company was founded by John Willard Marriott and Alice Sheets Marriott in 1927 and is headquartered in Bethesda, MD.

Marriott International, Inc. - Ordinary Shares - Class A

Marriott International Inc

Marriott International is trending as investors analyze its growth strategy and financial outlook following its recent earnings report. The community is focused on both revenue per available room (RevPAR) and the potential impact of broader economic trends on the travel sector. Recent data breaches and executive moves are also contributing to the discussion around the stock.

Wealthfront Corp.engages in the provision of automated digital investment advisory services. The company was founded by Andrew Samuel Rachleff and Daniel Joseph Carroll in January 2007 and is headquartered in Palo Alto, CA.

Wealthfront Corp.

Wealthfront ($WLTH) is trending following its IPO, with the community discussing its potential as a long-term play in the robo-advisor space and comparing it to competitors. Some are optimistic due to strong anchor support and the company's focus on millennial and Gen Z clients, while others are awaiting chart data and analyzing its initial trading behavior. The IPO was reportedly oversubscribed, and there's chatter about potential weekend advertising and significant upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Paul Rubin Sells 18,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of...

BioAge Labs (NASDAQ:BIOA) Insider Sells $216,000.00 in Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an...

Paul Rubin Sells 68,897 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 68,897 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average...

BioAge Labs (NASDAQ:BIOA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded BioAge Labs from a "sell" rating to a "hold" rating in a report on Saturday...

Jefferies Financial Group Inc. Buys Shares of 50,000 BioAge Labs, Inc. $BIOA

Jefferies Financial Group Inc. bought a new stake in BioAge Labs, Inc. (NASDAQ:BIOA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities...

BioAge Labs (NASDAQ:BIOA) Issues Quarterly Earnings Results

BioAge Labs (NASDAQ:BIOA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by...

BioAge Labs’ stock&nbsp;lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low following its decision to discontinue the STRIDES Phase 2 study of azelaprag, its investigational obesity drug.&nbsp;The halt, announced on Friday, came after some subjects in the azelaprag treatment arms showed elevated liver enzymes, though no clinically significant symptoms were reported.&nbsp;The tirzepatide-only treatment group did not exhibit transaminase elevations, according to the company.CEO Kristen Fortney said, "We made the difficult decision to discontinue the STRIDES Phase 2 study of azelaprag because it became clear that the emerging safety profile of the current doses tested is inconsistent with our goal of a best-in-class oral obesity therapy.”&nbsp;BioAge said it remains focused on developing therapies for metabolic aging and advancing its NLRP3 inhibitor program alongside other research initiatives.The news spurred swift Wall Street downgrades on Monday.&nbsp;Jefferies cut its rating from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7, noting the unexpected liver signal after a clean safety profile in eight prior Phase 1 studies by BioAge and Amgen.&nbsp;Citi also downgraded the stock to ‘Neutral’ from ‘Buy’, reducing its price target from $45 to $7. The brokerage highlighted that the liver toxicity concerns significantly limit azelaprag’s potential in obesity treatments and eliminate a key catalyst for BioAge’s shares.<figure class="image"><a href="https://stocktwits.com/symbol/BIOA"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_09_at_6_21_42_PM_bad10ec021.png" alt="Screenshot 2024-12-09 at 6.21.42 PM.png" width="1318" height="318"></a><figcaption>BIOA sentiment and message volume on Dec 9 premarket as of 7:45 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned sharply ‘bearish’ after the announcement, a reversal from ‘bullish’ levels the previous day.&nbsp;Investors expressed frustration over the trial’s discontinuation and the steep decline in share value.<stembedurl>https://stocktwits.com/ProKnifeCatcher87/message/595559186</stembedurl><stembedurl>https://stocktwits.com/texmade2/message/595509540</stembedurl>BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.

Jefferies cut its rating on BioAge from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7

BioAge Stock Nosedives On Obesity Drug Study Halt: Downgrades Crush Retail Sentiment

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.

Equity

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.


BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

BIOA
BioAge Labs Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIOA News

BIOABioAge Labs Inc.